Relapse Prevention Study in Patients With Schizophrenia
Study sponsor: Vanda Pharmaceuticals
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2014-03Actual
Enrollment · participants635Actual
Source updated2023-07-17Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.